Alain Carpentier

Research interests

Publications

• 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

  The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00160-7

• Eprenetapopt Plus Azacitidine in TP53 -Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.02342

• 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

  The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30336-5

• A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

  Neuro-Oncology · 2016 · https://doi.org/10.1093/neuonc/now009

• Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

  New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1308345

• VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer

  Cancer Research · 2012 · https://doi.org/10.1158/0008-5472.can-12-2325

• Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2008.17.5984

• Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model

  Cancer Immunology Immunotherapy · 2009 · https://doi.org/10.1007/s00262-009-0671-1

• Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.04.6078

• Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines

  The Journal of Immunology · 2006 · https://doi.org/10.4049/jimmunol.176.5.2722

• Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection

  The Journal of Immunology · 2004 · https://doi.org/10.4049/jimmunol.172.4.2137

Current projects

No projects listed.